Dong-A ST concludes co-development agreement of immunotherapy with AstraZeneca
Dong-A ST(CEO/Vice President Soo-Hyun Kang) announced on the 11th that the company signed a co-development agreement of innovative immunotherapies with AstraZeneca, an English biotech company, at JP Morgan Healthcare Conference in San Francisco, USA, on the 10th, 4pm.
With Dong-A ST Vice Preside...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
